Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

Investing

Biogen : BIIB

All Biogen Articles

607 Articles

Chris Lange | Feb 14, 2018 at 4:08 PM EST

Wednesday’s Biggest Winners and Losers in the S&P 500

Wednesday was a fourth consecutive positive day for the U.S. markets, again with a rocky start just like Tuesday. All…

Chris Lange | Feb 12, 2018 at 9:15 AM EST

Major Biotechs See Rising Tide of Short Interest

The January 31 short interest data have been compared with the previous report, and short interest in most of the…

Jon C. Ogg | Feb 5, 2018 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

The top analyst upgrades, downgrades and other research calls from Monday include Amgen, Boeing, Chevron, Exxon Mobil, Foot Locker, Lowe's,…

Jon C. Ogg | Jan 31, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot…

Chris Lange | Jan 25, 2018 at 10:05 AM EST

Short Sellers Raise the Stakes in Major Biotechs

The January 12 short interest data have been compared with the previous report, and short interest moves in the selected…

Jon C. Ogg | Jan 16, 2018 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Amazon.com, Boeing, Chesapeake Energy, Eli Lilly, Gilead Sciences,…

Chris Lange | Jan 11, 2018 at 9:50 AM EST

Short Sellers Grow More Selective on Major Biotechs

The December 29 short interest data have been compared with the previous report, and short interest in the selected biotech…

Chris Lange | Jan 8, 2018 at 4:08 PM EST

Monday’s Biggest Winners and Losers in the S&P 500

Although Monday was a relatively mixed day for the markets, all three of the major exchanges hit all-time highs yet…

Lee Jackson | Dec 31, 2017 at 10:15 AM EST

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be…

Chris Lange | Dec 28, 2017 at 11:50 AM EST

Top 10 Biopharma Events Kicking Off 2018

Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two…

Chris Lange | Dec 28, 2017 at 9:05 AM EST

Major Biotechs See Surge in Short Interest

The December 15 short interest data have been compared with the previous report, and short interest in the selected biotech…

Jon C. Ogg | Dec 20, 2017 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Alcoa, Extreme Networks, Gilead, MGIC, Micron, Noble Energy, Twitter, US Steel, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Alcoa, Extreme Networks, Gilead Sciences, MGIC, Micron, Noble…

Chris Lange | Dec 12, 2017 at 10:10 AM EST

Major Biotechs See Rising Tide in Short Interest

The November 30 short interest data have been compared with the previous report, and short interest in most of the…

Lee Jackson | Dec 11, 2017 at 9:50 AM EST

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

1 … 13 14 15 16 17 … 41

Biogen : BIIB

All Biogen Articles

Wednesday’s Biggest Winners and Losers in the S&P 500

Major Biotechs See Rising Tide of Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Short Sellers Grow More Selective on Major Biotechs

Monday’s Biggest Winners and Losers in the S&P 500

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Top 10 Biopharma Events Kicking Off 2018

Major Biotechs See Surge in Short Interest

Top Analyst Upgrades and Downgrades: Alcoa, Extreme Networks, Gilead, MGIC, Micron, Noble Energy, Twitter, US Steel, Wendy’s and More

Major Biotechs See Rising Tide in Short Interest

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

You Can Give From Your IRA Completely Tax-Free at 70½, Two and a Half Years Before RMDs Even Begin

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins

You Can Give From Your IRA Completely Tax-Free at 70½, Two and a Half Years Before RMDs Even Begin

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

Biogen : BIIB

All Biogen Articles

Wednesday’s Biggest Winners and Losers in the S&P 500

Major Biotechs See Rising Tide of Short Interest

Top Analyst Upgrades and Downgrades: Amgen, Boeing, Chevron, Exxon, Foot Locker, Lowe’s, Nokia, PayPal, Sprint, Wells Fargo and More

Top Analyst Upgrades and Downgrades: AK Steel, Apple, Biogen, EA, FitBit, Foot Locker, McDonald’s, Pfizer and More

Short Sellers Raise the Stakes in Major Biotechs

Top Analyst Upgrades and Downgrades: Amazon, Boeing, Chesapeake Energy, Eli Lilly, Gilead, Micron, NVIDIA, P&G, Qualcomm and More

Short Sellers Grow More Selective on Major Biotechs

Monday’s Biggest Winners and Losers in the S&P 500

Analysts Have 12 Top Biotech Picks for Big Upside in 2018

Top 10 Biopharma Events Kicking Off 2018

Major Biotechs See Surge in Short Interest

Top Analyst Upgrades and Downgrades: Alcoa, Extreme Networks, Gilead, MGIC, Micron, Noble Energy, Twitter, US Steel, Wendy’s and More

Major Biotechs See Rising Tide in Short Interest

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Live: Will Aehr Test Systems Crush Tonight’s Q4 Earnings After the Market Closes?

YMAX’s 1.33% Fee Is Just the Start: How a Fund-of-Funds Structure Is Quietly Stacking Costs on Top of Costs

How a Couple With $1 Million in Retirement Can Build a Tax-Efficient $2,392 Monthly Income Stream Using 2 Vanguard ETFs

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here’s Who Wins

Featured Reads

You Can Give From Your IRA Completely Tax-Free at 70½, Two and a Half Years Before RMDs Even Begin

Earned Over $145,000 Last Year? Your 401(k) Catch-Up Money Is Now Forced Into a Roth and Here's Who Wins